New test aims to predict which uterine cancers come back
NCT ID NCT04604613
Summary
This study aims to find out if a molecular test can predict whether low-risk endometrial cancer will return after a patient has surgery to remove it. Researchers are studying 518 patients who are scheduled for a hysterectomy. They will analyze tumor tissue and track patients for two years to see if the test results match who actually has a cancer recurrence.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIGO GRADE 1 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.